US20050203588A1 - Method for optimizing location of implanted electrode array during implant surgery - Google Patents

Method for optimizing location of implanted electrode array during implant surgery Download PDF

Info

Publication number
US20050203588A1
US20050203588A1 US11/031,648 US3164805A US2005203588A1 US 20050203588 A1 US20050203588 A1 US 20050203588A1 US 3164805 A US3164805 A US 3164805A US 2005203588 A1 US2005203588 A1 US 2005203588A1
Authority
US
United States
Prior art keywords
stimulation
electrode array
location
paresthesia
lead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/031,648
Inventor
John King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Neuromodulation Corp
Original Assignee
Advanced Bionics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionics Corp filed Critical Advanced Bionics Corp
Priority to US11/031,648 priority Critical patent/US20050203588A1/en
Priority to PCT/US2005/001119 priority patent/WO2006073405A2/en
Publication of US20050203588A1 publication Critical patent/US20050203588A1/en
Assigned to ADVANCED BIONICS CORPORATION reassignment ADVANCED BIONICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KING, JOHN D.
Assigned to BOSTON SCIENTIFIC NEUROMODULATION CORPORATION reassignment BOSTON SCIENTIFIC NEUROMODULATION CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ADVANCED BIONICS CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36071Pain
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/92Computer assisted medical diagnostics

Definitions

  • the present invention relates to Spinal Cord Stimulation (SCS) systems and more particularly to methods for efficiently searching for an effective SCS system stimulation parameter sets.
  • An SCS system treats chronic pain by providing electrical stimulation pulses through the electrodes of an electrode array placed epidurally next to a patient's spinal cord.
  • the stimulation parameter set determines the characteristics of the stimulation pulses provided through the electrode array, and the electrodes used to provide the stimulation pulses.
  • the optimal stimulation parameter set for a specific patient may be determined from the response of the patient to various sets of stimulation parameters. There is, however, an extremely large number of possible combinations of stimulation parameters, and evaluating all possible sets is very time consuming, and impractical.
  • An SCS system typically includes an Implantable Pulse Generator (IPG), electrodes, electrode lead, and electrode lead extension.
  • IPG Implantable Pulse Generator
  • the electrodes are implanted along the dura of the spinal cord, and the IPG generates electrical pulses that are delivered, through the electrodes, to the dorsal column and dorsal root fibers within the spinal cord.
  • Individual electrode contacts are arranged in a desired pattern and spacing in order to create an electrode array. Individual wires within one or more electrode leads connect with each electrode in the array.
  • the electrode leads exit the spinal column and generally attach to one or more electrode lead extensions.
  • the electrode lead extensions are typically tunneled around the torso of the patient to a subcutaneous pocket where the IPG is implanted.
  • Electrodes are selectively programmed to act as anodes, cathodes, or left off, creating a stimulating group.
  • the number of stimulation groups available combined with the ability of integrated circuits to generate a variety of complex stimulation pulses, presents a huge selection of stimulation parameter sets to the clinician.
  • a “fitting” procedure is performed to select an effective stimulation parameter set for a particular patient.
  • a known practice is to manually test one parameter set, and then select a new stimulation parameter set to test, and compare the results.
  • Each parameter set is painstakingly configured, and ramped up in amplitude gradually to avoid patient discomfort.
  • the clinician bases their selection of a new stimulation parameter set on their personal experience and intuition. There is no systematic method to guide the clinician. If the selected stimulation parameters are not an improvement, the clinician repeats these steps, using a new stimulation parameter set, based only on dead-reckoning. The combination of the time required to test each parameter set, and the number of parameter sets tested, results in a very time consuming process.
  • the lead or leads should be placed in a location such that the electrical stimulation will affect the targeted nerves and cause paresthesia.
  • the paresthesia perceived by the patient and induced by the stimulation should be located in approximately the same place in the patient's body as the pain that is the target of treatment. If a lead is not correctly positioned, it is possible that the patient will receive little or no benefit from an implanted SCS system. Thus, correct lead placement can mean the difference between effective and ineffective pain therapy.
  • surgeons use various methods in order to determine if a lead is correctly positioned during the surgical implant procedure.
  • One method involves providing stimulation using one electrode combination and then physically moving the electrode array along the spinal cord dura with the stimulation remaining “on.” This method is known as “trolling.” The patient provides feedback as to the effectiveness of the stimulation as the electrode array is moved. Once an approximately effective location is identified, the electrode array is fixed in that position.
  • This method has several disadvantages, including the fact that only one electrode combination is used and the possible benefits of different electrode combinations are not explored. Additionally, this method involves a more complicated surgical procedure that presents additional risks to the patient.
  • Another method for determining whether an electrode array is correctly positioned during a surgical procedure involves testing a variety of combinations of electrodes, one at a time.
  • the lead is implanted in a location that the surgeon believes will be effective.
  • Stimulation is activated and then painstakingly ramped up for one electrode combination.
  • the patient then provides feedback as to the effectiveness of that combination.
  • the stimulation is then ramped down to zero, and the process is repeated for another electrode combination. If no combinations produce a satisfactory result, the surgeon moves the electrode array and the process is repeated. This method can result in a time consuming and frustrating surgical procedure for the patient.
  • What are needed are methods for selection of trial stimulation parameter sets that guide the clinician towards an effective stimulation parameter set(s). What are also needed are methods for quickly and simply determining whether an electrode array is correctly positioned during a surgical procedure.
  • the present invention addresses the above and other needs by providing a method for selecting trial Spinal Cord Stimulation (SCS) stimulation parameter sets, which method guides a clinician towards an effective set of stimulation parameters.
  • SCS Spinal Cord Stimulation
  • a table, or equivalent, of a small number of trial stimulation parameter sets (a coarse table) that defines a starting point for selecting a stimulation parameter set.
  • a larger table (a fine table), or equivalent, of predetermined stimulation parameter sets to guide the search for a local optimum. Any method for finding an effective stimulation parameter set that uses a combination of a small coarse table, or equivalent, and a large fine table, or equivalent, is intended to come within the scope of the invention.
  • the clinician first evaluates the effectiveness of a small number of trial stimulation parameter sets from a Simplified Measurement Table comprising for example, four stimulation parameter sets. Based on the patient's assessment, the trial stimulation parameter sets are ranked. Then the clinician selects a starting row in a Simplified Steering Table corresponding to the highest ranked trial stimulation parameter set. The clinician moves either up or down from the starting row, testing consecutive parameter sets. The clinician continues as long as the patient indicates that the stimulation results are improving. When a local optimum is found, the clinician returns to the starting row, and tests in the opposite direction for another local optimum. If an acceptable set of stimulation parameters if found, the selection process is complete. If an acceptable set is not found, a new starting row in the Simplified Steering Table is selected based on the next best trial stimulation parameter set, and the process of searching for local optima is repeated.
  • a Simplified Measurement Table comprising for example, four stimulation parameter sets. Based on the patient's assessment, the trial stimulation parameter sets are ranked. The clinician selects a
  • a method for searching for an effective set of stimulation parameters for an SCS system improves the efficiency of the search by organizing the search based on predetermined stimulation parameter sets.
  • a clinician first ranks the effectiveness of a very small set of trial stimulation parameter sets, and then searches for an optimum stimulation set around the highest ranked trial stimulation parameter set.
  • a method for determining an effectual placement of an electrode array during a surgical procedure to implant the lead involves placing a lead having electrodes in a first location in a patient then (1) activating electrical stimulation to produce paresthesia, (2) “electronically trolling” the length of the electrode array and (3) determining whether the paresthesia induced by the stimulation is in an effective location. If the paresthesia is not in an effective location to match the pain, the lead is moved to a different location and steps (1) through (3) are repeated.
  • the electrical stimulation is defined by parameters specified by software, which may include a steering table used for trolling.
  • the steering table may include multiple rows arranged so that the electric field properties of adjacent rows are similar.
  • the process of electronically trolling involves moving the electrical stimulation along the electrode array so that all regions of the electrode array provide stimulation. This may involve moving from a first end of the electrode array to the opposite end of the electrode array, and may involve moving “up” and/or “down” through a steering table.
  • This method reduces or eliminates the need to continually move the lead and electrode array during the implant procedure while still allowing the electric field produced by the stimulating electrodes to be moved. This method thus simplifies the implant procedure compared to the physical trolling method and reduces the risks to the patient. Additionally, this method saves time by allowing multiple electrode combinations to be tested in a shorter amount of time than the known method of painstakingly ramping stimulation up and down to test a single electrode combination.
  • FIG. 1 shows a Spinal Cord Stimulation (SCS) system
  • FIG. 2 depicts the SCS system of FIG. 1 implanted in a spinal column
  • FIG. 3 depicts a stimulation parameter set flow chart according to one embodiment of the present invention.
  • FIG. 4 depicts an electronic trolling flow chart according to one embodiment of the present invention.
  • Appendix A comprising 2 pages including a cover, is an example of a Simplified Measurement Table.
  • Appendix B comprising 13 pages including a cover, is an example of a Simplified Steering Table.
  • the method of the present invention provides a systematic approach for selecting a Spinal Cord Stimulation (SCS) stimulation parameter set.
  • SCS Spinal Cord Stimulation
  • the method leads a clinician through a selection process that efficiently locates locally optimum stimulation parameter sets.
  • FIG. 1 A typical Spinal Cord Stimulation (SCS) system 10 is shown in FIG. 1 .
  • the SCS system 10 typically comprises an Implantable Pulse Generator (IPG) 12 , a lead extension 14 , an electrode lead 16 , and an electrode array 18 .
  • the IPG 12 generates stimulation current for implanted electrodes that make up the electrode array 18 .
  • a proximal end of the lead extension 14 is removably connected to the IPG 12 and a distal end of the lead extension 14 is removably connected to a proximal end of the electrode lead 16 , and electrode array 18 is formed on a distal end of the electrode lead 16 .
  • the in-series combination of the lead extension 14 and electrode lead 16 carry the stimulation current from the IPG 12 to the electrode array 18 .
  • the SCS system 10 described in FIG. 1 above, is depicted implanted in the epidural space 20 in FIG. 2 .
  • the electrode array 18 is implanted at the site of nerves that are the target of stimulation, e.g., along the spinal cord. Due to the lack of space near the location where the electrode lead 16 exits the spinal column, the IPG 12 is generally implanted in the abdomen or above the buttocks.
  • the lead extension 14 facilitates locating the IPG 12 away from the electrode lead exit point.
  • FIG. 3 A flow chart representing one embodiment of a method for stimulation parameter set selection in accordance with the present invention is depicted in FIG. 3 . As with most flow charts, each step or act of the method is represented in a “box” or “block” of the flow chart. Each box or block, in turn, has a reference number associated with it to help explain the process in the description that follows.
  • the measurement table typically comprises rows, with each row defining one set of stimulation parameters.
  • each row specifies the polarity on each electrode of the electrode array 18 ( FIGS. 1 and 2 ) that the stimulation system determines should be applied to the patient for a particular purpose.
  • the electrode array 18 preferably comprises eight or sixteen electrodes, but the measurement table may only utilize a subset of the electrode array 18 , for example four electrodes.
  • a measurement table may include stimulation parameter sets with various variations, such as pulse duration or pulse frequency, and a measurement table with such other variations is intended to come within the scope of the present invention.
  • An exemplary simplified measurement table that may be used with the invention is found in Appendix A.
  • the steering table typically includes a larger number of rows than does the measurement table.
  • An exemplary steering table, containing 541 rows, that may be used with the invention is found in Appendix B.
  • the rows in the steering table typically reflect the same variation as the rows in the measurement table, however, those skilled in the art will recognize that the steering table may also include other degrees of variation not included in the measurement table, and these variations are also intended to come within the scope of the invention. At least one row in the steering table will however correspond to one of the rows in the measurement table, as will be made apparent by the following description.
  • the rows in the steering table are arranged in order based on the physical characteristics of the stimulation provided by each stimulation parameter set, so that moving from one row to the next in the steering table represents a gradual, and somewhat uniform, change in stimulation. In other words, stepping from one row to an adjacent row in the steering table causes the stimulation applied to the tissue through the individual electrodes of the electrode array 18 to gradually move in a desired direction.
  • This type of current steering is described more fully in U.S. Pat. No. 6,393,325, incorporated herein by reference.
  • the first step in the method is selection of a trial stimulation parameter set (block 24 ).
  • the first row of the measurement table will be tested first, followed in order by the remaining rows. However, the order of row selection is not essential, and the rows may be selected in any order.
  • the selected stimulation parameter set is used to provide stimulation to the patient (block 26 ).
  • the amplitude of the stimulation provided is initially set to a relatively low level, i.e., below the level that will result in the patient perceiving paresthesia. The amplitude is then gradually increased. The stimulation level at which the patient begins to perceive paresthesia is called the perception or perceptual threshold.
  • the patient provides feedback as to the effectiveness of the stimulation that has been applied using the trial stimulation parameter set.
  • Alternative means e.g., objective measurements of various physiological parameters of the patient, such as perspiration, muscle tension, respiration rate, heart rate, and the like
  • a determination is then made if all of the trial sets have been tested (block 28 ).
  • the steps of selecting a trial set of stimulation parameters (block 24 ) and providing stimulation in accordance with the selected trial set of stimulation parameters (block 26 ) are repeated until all of the trial stimulation parameter sets have been tested.
  • the trial stimulation parameter sets are ranked (block 30 ) based upon the patient's evaluation (and/or based upon alternative evaluation of selected physiological parameters of the patient) of the effectiveness of each trial stimulation parameter set.
  • the testing and ranking of the trial stimulation parameter sets provides a coarse approximation of the stimulation which may be most effective. Because the, trial stimulation parameter set is only a coarse approximation, the implication is that fine adjustments of such parameter sets may also be effective, and perhaps even more effective.
  • the highest ranked trial stimulation parameter set becomes a first specified ranked set that functions as a first “benchmark,” or starting point, for a much finer search for the most effective stimulation parameter set.
  • the finer search for a stimulation parameter set begins by selecting a row in the steering table that corresponds to the highest ranked set in the measurement table (block 32 a ). This selected highest ranked trial stimulation parameter set is then used to provide stimulation (block 34 a ) to the patient.
  • the patient evaluates the effectiveness of the stimulation, and/or alternative means (e.g., measuring physiological parameters of the patient) are used to evaluate the effectiveness of the stimulation.
  • a row next to the row just tested e.g., moving in a first direction in the steering table, such as down, is selected as a possible new stimulation parameter set (block 36 ), and this new row is then used to provide stimulation (block 34 b ).
  • the results of the new stimulation are then compared to the results of the previous stimulation (block 38 a ).
  • the steps set forth in blocks 36 and 34 b are repeated, i.e., the row in the steering table adjacent to the most recently used row, moving in the same direction in the table as before, is used to define a new stimulation parameter set (block 36 ) and that stimulation parameter set is used to provide stimulation (block 34 b ).
  • this process of stepping to the next row in the steering table and retesting is continued, thereby fine tuning the stimulation parameter set until no further improvements are detected.
  • the method goes back to the “benchmark” parameter set, i.e., that row in the steering table corresponding to the highest ranked set (block 32 b ) and stimulation is again provided (block 34 c ).
  • This is actually a repeat of the stimulation performed at blocks 32 a and 34 a, but inasmuch as one or more stimulation parameter sets have been provided since the benchmark stimulation was provided at steps 32 a and 34 a, this repeat stimulation provides the patient with a reminder or refresher of what the benchmark stimulation was like. (Alternatively, of course, this repeat of the benchmark stimulation could be skipped.) Then, a process almost identical to that described above is performed to again fine tune the benchmark stimulation parameter set, only in the other direction.
  • the row adjacent to the row that defines the benchmark stimulation parameter set is selected as the row that defines the stimulation parameter set (block 40 ), moving in the opposite direction, e.g., up, from the direction used in the step performed at block 36 .
  • stimulation is provided using the parameters of the selected row (block 34 d ).
  • the results of the new stimulation applied at step 34 d are compared to the results of the previous stimulation (block 38b). If the results improve (YES branch of block 38 b ), the steps set forth in blocks 40 and 34 d are repeated, i.e., the row in the steering table adjacent to the most recently used row, moving in the same direction in the table as before, are used to define a new stimulation parameter set (block 40 ), and that stimulation parameter set is used to provide stimulation (block 34 d ). As long as the stimulation results continue to improve, this process of stepping to the next row in the steering table, and retesting is continued, thereby fine tuning the stimulation parameter set until no further improvements are detected.
  • two sets of effective stimulation parameters have been identified: one by moving in a first direction from the benchmark row (of the specified ranked set) in the steering table (determined using the steps at blocks 36 , 34 b and 38 a ), and another by moving from the benchmark row in a second direction in the steering table (determined using the steps at blocks 40 , 34 d and 38 b ).
  • These two possible stimulation sets are then evaluated to see if one comprises the most effective stimulation set (block 42 ). If so (YES branch of block 42 ), then that set is selected as the best parameter stimulation set for the stimulation that is to be provided (block 46 ) whenever the operating program of the SCS system (or other neural system) determines stimulation is needed.
  • next highest ranked set (block 44 )
  • the next highest ranked set thus defines a new specified “benchmark” stimulation set from which additional fine tuning is performed as described above (blocks 32 a through 38 b ).
  • Stimulation Set No. 301 which shows that the current flow from Electrode 3 is “1” and the current flow from Electrode 5 is “ ⁇ 1”. This means that all of the current applied by the stimulator is applied from Electrode 3 as an anode to Electrode 5 as a cathode.
  • Stimulation Set No. 301 serves as the first “benchmark” stimulation set.
  • the method then fine tunes this selection by applying the stimulation set(s) adjacent the benchmark set. For example, going “down” in the Simplified Steering Table, Stimulation Set No. 302 is applied, then No. 303 , and then No. 304 , and so on, until the patient (or other means) determines that no further improvement results. In this example, Stimulation Set No. 302 is found to be the most effective set.
  • Stimulation Set No. 300 is applied, then No. 299 , then No. 298 , and so on, until the patient (or other means) determines that no further improvement results.
  • Stimulation Set 298 is found to be the most effective set to use.
  • Stimulation Set No. 298 and 302 have been identified, then a determination is made as to which one is the most effective to use for stimulation. If one of these two is the most effective, e.g., Stimulation Set No. 298 , then that Stimulation Set is selected as the best one to use for stimulation in this instance, and the search ends. If, however, neither is found to be the most effective, then the process continues by locating the second-highest ranked benchmark stimulation set (corresponding to Stimulation Set No. 1 in the Simplified Measurement Table) in the Simplified Steering Table. As seen from the Simplified Measurement Table, Stimulation Set No. 1 defines Electrode No. 1 as a cathode and Electrode No. 3 as an anode.
  • the two stimulation sets identified from fine tuning the second benchmark stimulation set are then evaluated to determine if one if the most effective to use for stimulation. If one of these two is the most effective, then that stimulation set is selected as the best one to use for stimulation in this instance, and the search ends. If, however, neither is found to be the most effective, then the process continues by locating the third-highest ranked benchmark stimulation set (corresponding to Stimulation Set No. 2 in the Simplified Measurement Table) in the Simplified Steering Table, and the process continues as described.
  • a gradient method may be utilized to evaluate the slope of stimulation parameter set effectiveness around each trial stimulation parameter set.
  • a combination of the relative effectiveness of each trial stimulation parameter set, and the slope of the effectiveness in the neighborhood of the trial stimulation parameter set may be used to select which trial stimulation parameter set to test around.
  • the basic core of the present invention is to use a table, or equivalent, of a small number of trial stimulation parameter sets (a coarse table) to determine a starting point, and a larger table (a fine table), or equivalent, of predetermined stimulation parameter sets to guide the search for a local optimum. Any method for finding an effective stimulation parameter set that uses a combination of a small coarse table, and a large fine table, is intended to come within the scope of the invention.
  • FIG. 4 A flow chart depicting one embodiment of these methods is shown in FIG. 4 .
  • a lead 16 containing an electrode array 18 is placed epidurally next to a patient's spinal cord in a location believed to be the correct location for effective treatment (block 50 ). This location may be estimated based on, for instance, mapping the location of the pain to spinal segments via dermatome maps.
  • the pulse generator may be an external trial stimulator (ETS), an implantable pulse generator (IPG) 12 or another source of stimulation.
  • the lead may be connected directly to the pulse generator, or may be electrically connected, for instance, via a lead extension 14 and/or an operating room (OR) cable.
  • ETS external trial stimulator
  • IPG implantable pulse generator
  • OR operating room
  • a steering table such as the steering table shown in Appendix B is used to define the stimulation parameters.
  • the table entries are arranged so that the electric field properties of the stimulation defined by parameters in adjacent rows are similar. This is accomplished by having the rows arranged in order based on the characteristics of the stimulation provided by each stimulation parameter set, so that moving from one row to an adjacent row in the steering table causes a gradual change in stimulation.
  • rows 21 to 41 of the table in Appendix B define stimulation parameters representing a gradual transition of an anode from electrode 3 to electrode 4 .
  • the electric field properties of the stimulation defined by the parameters in these rows are similar, such that a transition from row 21 to row 41 has the effect of gradually moving the anode from electrode 3 to electrode 4 .
  • the steering table is arranged such that stimulation is first provided by an electrode located at one end of the electrode array.
  • the entries of the table are arranged so that the stimulation is gradually transitioned to an adjacent electrode, then another adjacent electrode, and so on, until the stimulation has been transitioned along the entire length of the array.
  • the number of steps used to transition along the entire array, and thus the number of entries in the steering table used for trolling depends on many factors. These factors include the number of electrodes in the array and the maximum step size that will not produce an uncomfortable “jolt” to the patient.
  • the amount of time the surgeon and/or patient wants to spend trolling and the amount of time the patient can tolerate trolling must be weighed against the desired electric field shift resolution. If too large of a step size is selected, a group of effective stimulation parameter sets might be inadvertently skipped during the trolling process and the location of the lead may be incorrectly judged to be ineffective.
  • the number of steps or step size may be programmable and selectable by the surgeon and/or clinician, or may be pre-programmed in software. Once the number of steps or step size is determined, a steering table for use in trolling can be created or can be selected from an existing table. Alternatively, particular rows from a larger steering table may be selected for use in the trolling process.
  • the stimulation is first provided by an electrode or set of electrodes that is not at the end of the array. For example, several electrodes in the middle of the array may be used to provide stimulation. The stimulation is then transitioned in one direction along the array to one end of the array. The stimulation may then be transitioned back to the middle of the array and to the opposite end of the array. In this way, stimulation is provided from electrodes located in different regions of the array. Any combination or pattern in which stimulation is transitioned along the length of the array is intended to fall within the scope of these methods.
  • stimulation may be defined by parameters specified by software, which may define multiple sets of stimulation parameters.
  • stimulation may be activated in one portion of an array and an algorithm may be used to transition stimulation from that portion of the electrode array to another or from one end of the array to the other without the use of a steering table.
  • Fixed step sizes may be used to transition stimulation, or a method such as the method disclosed in co-pending U.S. application Ser. No. ##/###,###, filed Dec. 30, 2004 entitled “Method for Optimizing Search for Spinal Cord Stimulation Parameter Settings” and incorporated herein by reference, may be used to determine the appropriate step sizes to use for electronic trolling.
  • the electronic trolling process preferably involves electrodes from all regions of the array. If the trolling process involves less than the entire array, then a relatively smaller region of the patient's spinal cord is stimulated during the trolling process and the lead may have to be repositioned a greater number of times. To avoid this less efficient result and to gain the maximum benefit of the methods discussed above, a representative number of sets of stimulation parameters are preferably used during the trolling process. This means that sets of stimulation parameters defining stimulation in all regions of the electrode array are preferably used, and that a sufficient number of sets are preferably used.
  • the number of sets required depends on several factors, including the number and size of electrodes, the inter-electrode spacing, the patient's anatomy and the location(s) and total area of the patient's pain. This number is preferably chosen so that the electric field and the resulting paresthesia do not shift too much with each transition in the trolling process, and so that stimulation is provided from all regions of the electrode array.
  • the electrical stimulation should be of a strong enough intensity to produce paresthesia along the entire length of the array. Any method that accomplishes this can be used, including giving the patient the ability to manually adjust the intensity of the stimulation up and down as the stimulation is transitioned.
  • an algorithm such as the SEQ algorithm described in co-pending U.S. application Ser. No. ##/###,###, discussed above, may be used to maintain a relatively constant stimulation intensity as the stimulation is transitioned. As the electric field produced by the stimulation is shifted, the location on the patient's body where paresthesia is sensed will also shift.
  • the goal of the trolling process is to ensure the effective placement of an electrode array such that the location of the induced paresthesia is effective, i.e., so that the location of the induced paresthesia matches the location of the pain when the electrode array is located in a particular place.
  • the patient reports whether the paresthesia generated by the stimulation is located in approximately the same location as the pain (block 56 ).
  • the patient may provide feedback during the trolling process, or may be asked at the conclusion of the trolling process whether the location of the paresthesia matched the location of the pain at any time during the process. If the location of the paresthesia sufficiently matches the location of the pain, then the lead is in an effective position and the trolling process is complete (block 58 ). The surgeon then secures the lead in position, using a lead anchor or other means.
  • the process of determining effectual stimulation parameter sets for example as shown in FIG. 3 and described above, may then begin (block 64 ).
  • the stimulation may optionally be deactivated (block 60 ), the lead is repositioned in the epidural space (block 62 ) and the steps shown in blocks 52 - 56 are repeated. This process of optionally deactivating stimulation, repositioning the lead, and repeating the steps in blocks 52 - 56 is repeated until the patient reports that the paresthesia generated by the stimulation sufficiently matches the location of the pain.
  • electronic trolling has a similar effect as physical trolling in that the location of the electric field produced by the stimulation moves with respect to nerves in the spinal cord.
  • the lead need not be moved while the stimulation is active. Instead, the stimulation provided by the electrode array is moved along the array electronically by changing which electrode or electrodes are providing stimulation.
  • the lead is not moved unless the patient reports that the paresthesia produced by the stimulation does not sufficiently match the location of the pain. This results in a simpler surgical procedure with less risk of damage to tissue surrounding the lead or to the spinal cord itself. Additionally, because stimulation is not deactivated between testing each electrode combination, electronic trolling saves time over conventional methods which require stimulation to be ramped up and down in order to test each combination.

Abstract

A method for determining an effectual placement of an electrode array during a surgical procedure to implant the lead is provided. This method involves placing a lead having electrodes in a first location in a patient then (1) activating electrical stimulation to produce paresthesia, (2) “electronically trolling” the length of the electrode array and (3) determining whether the paresthesia is in an effective location. If the paresthesia is not in an effective location to match the location of the pain, the lead is moved to a different location steps (1) through (3) are repeated. The process of electronically trolling involves moving the electrical stimulation along the electrode array so that all regions of the electrode array provide stimulation. This method reduces or eliminates the need to move the lead during the implant procedure and thus simplifies the implant procedure compared to the currently used physical trolling method, reducing the risks to the patient. Additionally, this method saves time and improves outcomes by allowing multiple electrode combinations to be tested in a relatively short amount of time.

Description

  • This application is a continuation-in-part of, and claims the benefit of priority to, U.S. application Ser. No. 10/355,955, filed Jan. 31, 2003, which claims the benefit of and priority to U.S. Provisional Application Ser. No. 60/354,098, filed Feb. 4, 2002. These prior applications are incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • The present invention relates to Spinal Cord Stimulation (SCS) systems and more particularly to methods for efficiently searching for an effective SCS system stimulation parameter sets. An SCS system treats chronic pain by providing electrical stimulation pulses through the electrodes of an electrode array placed epidurally next to a patient's spinal cord. The stimulation parameter set determines the characteristics of the stimulation pulses provided through the electrode array, and the electrodes used to provide the stimulation pulses. The optimal stimulation parameter set for a specific patient may be determined from the response of the patient to various sets of stimulation parameters. There is, however, an extremely large number of possible combinations of stimulation parameters, and evaluating all possible sets is very time consuming, and impractical.
  • Spinal cord stimulation is a well accepted clinical method for reducing pain in certain populations of patients. An SCS system typically includes an Implantable Pulse Generator (IPG), electrodes, electrode lead, and electrode lead extension. The electrodes are implanted along the dura of the spinal cord, and the IPG generates electrical pulses that are delivered, through the electrodes, to the dorsal column and dorsal root fibers within the spinal cord. Individual electrode contacts (the “electrodes”) are arranged in a desired pattern and spacing in order to create an electrode array. Individual wires within one or more electrode leads connect with each electrode in the array. The electrode leads exit the spinal column and generally attach to one or more electrode lead extensions. The electrode lead extensions, in turn, are typically tunneled around the torso of the patient to a subcutaneous pocket where the IPG is implanted.
  • Spinal cord stimulators and other stimulation systems are known in the art. For example, an implantable electronic stimulator is disclosed in U.S. Pat. No. 3,646,940 issued Mar. 7, 1972 for “Implantable Electronic Stimulator Electrode and Method” that provides timed sequenced electrical impulses to a plurality of electrodes. As another example, U.S. Pat. No. 3,724,467 issued Apr. 3, 1973 for “Electrode Implant For The Neuro-Stimulation of the Spinal Cord,” teaches an electrode implant for the neuro-stimulation of the spinal cord. A relatively thin and flexible strip of physiologically inert plastic is provided as a carrier on which a plurality of electrodes are formed. The electrodes are connected by leads to an RF receiver, which is also implanted.
  • In U.S. Pat. No. 3,822,708, issued Jul. 9, 1974 for “Electrical Spinal Cord Stimulating Device and Method for Management of Pain,” another type of electrical spinal cord stimulation device is taught. The device disclosed in the '708 patent has five aligned electrodes, which are positioned longitudinally on the spinal cord. Electrical pulses applied to the electrodes block perceived intractable pain, while allowing passage of other sensations. A patient operated switch allows the patient to adjust the stimulation parameters.
  • Most of the electrode arrays used with known SCS systems employ between 4 and 16 electrodes. Electrodes are selectively programmed to act as anodes, cathodes, or left off, creating a stimulating group. The number of stimulation groups available, combined with the ability of integrated circuits to generate a variety of complex stimulation pulses, presents a huge selection of stimulation parameter sets to the clinician. When an SCS system is implanted, a “fitting” procedure is performed to select an effective stimulation parameter set for a particular patient.
  • A known practice is to manually test one parameter set, and then select a new stimulation parameter set to test, and compare the results. Each parameter set is painstakingly configured, and ramped up in amplitude gradually to avoid patient discomfort. The clinician bases their selection of a new stimulation parameter set on their personal experience and intuition. There is no systematic method to guide the clinician. If the selected stimulation parameters are not an improvement, the clinician repeats these steps, using a new stimulation parameter set, based only on dead-reckoning. The combination of the time required to test each parameter set, and the number of parameter sets tested, results in a very time consuming process.
  • In order to achieve an effective result from spinal cord stimulation, the lead or leads should be placed in a location such that the electrical stimulation will affect the targeted nerves and cause paresthesia. The paresthesia perceived by the patient and induced by the stimulation should be located in approximately the same place in the patient's body as the pain that is the target of treatment. If a lead is not correctly positioned, it is possible that the patient will receive little or no benefit from an implanted SCS system. Thus, correct lead placement can mean the difference between effective and ineffective pain therapy.
  • Presently, surgeons use various methods in order to determine if a lead is correctly positioned during the surgical implant procedure. One method involves providing stimulation using one electrode combination and then physically moving the electrode array along the spinal cord dura with the stimulation remaining “on.” This method is known as “trolling.” The patient provides feedback as to the effectiveness of the stimulation as the electrode array is moved. Once an approximately effective location is identified, the electrode array is fixed in that position. This method has several disadvantages, including the fact that only one electrode combination is used and the possible benefits of different electrode combinations are not explored. Additionally, this method involves a more complicated surgical procedure that presents additional risks to the patient.
  • Another method for determining whether an electrode array is correctly positioned during a surgical procedure involves testing a variety of combinations of electrodes, one at a time. In this method, the lead is implanted in a location that the surgeon believes will be effective. Stimulation is activated and then painstakingly ramped up for one electrode combination. The patient then provides feedback as to the effectiveness of that combination. The stimulation is then ramped down to zero, and the process is repeated for another electrode combination. If no combinations produce a satisfactory result, the surgeon moves the electrode array and the process is repeated. This method can result in a time consuming and frustrating surgical procedure for the patient.
  • What are needed are methods for selection of trial stimulation parameter sets that guide the clinician towards an effective stimulation parameter set(s). What are also needed are methods for quickly and simply determining whether an electrode array is correctly positioned during a surgical procedure.
  • SUMMARY OF THE INVENTION
  • The present invention addresses the above and other needs by providing a method for selecting trial Spinal Cord Stimulation (SCS) stimulation parameter sets, which method guides a clinician towards an effective set of stimulation parameters.
  • In accordance with one aspect of the invention, there is provided a table, or equivalent, of a small number of trial stimulation parameter sets (a coarse table) that defines a starting point for selecting a stimulation parameter set. There is also provided a larger table (a fine table), or equivalent, of predetermined stimulation parameter sets to guide the search for a local optimum. Any method for finding an effective stimulation parameter set that uses a combination of a small coarse table, or equivalent, and a large fine table, or equivalent, is intended to come within the scope of the invention.
  • In accordance with another aspect of the invention, the clinician first evaluates the effectiveness of a small number of trial stimulation parameter sets from a Simplified Measurement Table comprising for example, four stimulation parameter sets. Based on the patient's assessment, the trial stimulation parameter sets are ranked. Then the clinician selects a starting row in a Simplified Steering Table corresponding to the highest ranked trial stimulation parameter set. The clinician moves either up or down from the starting row, testing consecutive parameter sets. The clinician continues as long as the patient indicates that the stimulation results are improving. When a local optimum is found, the clinician returns to the starting row, and tests in the opposite direction for another local optimum. If an acceptable set of stimulation parameters if found, the selection process is complete. If an acceptable set is not found, a new starting row in the Simplified Steering Table is selected based on the next best trial stimulation parameter set, and the process of searching for local optima is repeated.
  • In accordance with yet another aspect of the invention, there is provided a method for searching for an effective set of stimulation parameters for an SCS system. The method improves the efficiency of the search by organizing the search based on predetermined stimulation parameter sets. A clinician first ranks the effectiveness of a very small set of trial stimulation parameter sets, and then searches for an optimum stimulation set around the highest ranked trial stimulation parameter set.
  • It is thus a feature of the present invention to provide a method for determining a locally optimum SCS system stimulation parameter set without requiring exhaustive testing of a multiplicity of stimulation parameter sets. Millions of possible stimulation parameter sets exist, and it is therefore impossible to test all possible sets. Therefore the clinician must be satisfied by finding an effective stimulation parameter set. By providing a systematic method for searching for an effective stimulation parameter set, a locally optimum stimulation parameter set is found, which locally optimum stimulation parameter set is associated with a best trial stimulation parameter set.
  • In accordance with another aspect of the invention, there is provided a method for determining an effectual placement of an electrode array during a surgical procedure to implant the lead. This method involves placing a lead having electrodes in a first location in a patient then (1) activating electrical stimulation to produce paresthesia, (2) “electronically trolling” the length of the electrode array and (3) determining whether the paresthesia induced by the stimulation is in an effective location. If the paresthesia is not in an effective location to match the pain, the lead is moved to a different location and steps (1) through (3) are repeated. The electrical stimulation is defined by parameters specified by software, which may include a steering table used for trolling. The steering table may include multiple rows arranged so that the electric field properties of adjacent rows are similar. The process of electronically trolling involves moving the electrical stimulation along the electrode array so that all regions of the electrode array provide stimulation. This may involve moving from a first end of the electrode array to the opposite end of the electrode array, and may involve moving “up” and/or “down” through a steering table.
  • This method reduces or eliminates the need to continually move the lead and electrode array during the implant procedure while still allowing the electric field produced by the stimulating electrodes to be moved. This method thus simplifies the implant procedure compared to the physical trolling method and reduces the risks to the patient. Additionally, this method saves time by allowing multiple electrode combinations to be tested in a shorter amount of time than the known method of painstakingly ramping stimulation up and down to test a single electrode combination.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The above and other aspects of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:
  • FIG. 1 shows a Spinal Cord Stimulation (SCS) system;
  • FIG. 2 depicts the SCS system of FIG. 1 implanted in a spinal column; and
  • FIG. 3 depicts a stimulation parameter set flow chart according to one embodiment of the present invention.
  • FIG. 4 depicts an electronic trolling flow chart according to one embodiment of the present invention.
  • Corresponding reference characters indicate corresponding components throughout the several views of the drawings.
  • Appendix A, comprising 2 pages including a cover, is an example of a Simplified Measurement Table.
  • Appendix B, comprising 13 pages including a cover, is an example of a Simplified Steering Table.
  • Appendices A and B are incorporated herein by reference.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
  • The method of the present invention provides a systematic approach for selecting a Spinal Cord Stimulation (SCS) stimulation parameter set. The method leads a clinician through a selection process that efficiently locates locally optimum stimulation parameter sets.
  • A typical Spinal Cord Stimulation (SCS) system 10 is shown in FIG. 1. The SCS system 10 typically comprises an Implantable Pulse Generator (IPG) 12, a lead extension 14, an electrode lead 16, and an electrode array 18. The IPG 12 generates stimulation current for implanted electrodes that make up the electrode array 18. A proximal end of the lead extension 14 is removably connected to the IPG 12 and a distal end of the lead extension 14 is removably connected to a proximal end of the electrode lead 16, and electrode array 18 is formed on a distal end of the electrode lead 16. The in-series combination of the lead extension 14 and electrode lead 16, carry the stimulation current from the IPG 12 to the electrode array 18.
  • The SCS system 10 described in FIG. 1 above, is depicted implanted in the epidural space 20 in FIG. 2. The electrode array 18 is implanted at the site of nerves that are the target of stimulation, e.g., along the spinal cord. Due to the lack of space near the location where the electrode lead 16 exits the spinal column, the IPG 12 is generally implanted in the abdomen or above the buttocks. The lead extension 14 facilitates locating the IPG 12 away from the electrode lead exit point.
  • A more detailed description of a representative SCS system that may be used with the present invention is described in U.S. Pat. No. 6,516,227, issued Feb. 4, 2003, incorporated herein by reference. It is to be emphasized, however, that the invention herein described may be used with many different types of stimulation systems, and is not limited to use only with the representative SCS system described in the 6,516,227 patent.
  • A flow chart representing one embodiment of a method for stimulation parameter set selection in accordance with the present invention is depicted in FIG. 3. As with most flow charts, each step or act of the method is represented in a “box” or “block” of the flow chart. Each box or block, in turn, has a reference number associated with it to help explain the process in the description that follows.
  • At the start 22 of the method, a measurement table, or equivalent, and a steering table, or equivalent, are provided. The measurement table typically comprises rows, with each row defining one set of stimulation parameters. In a preferred embodiment, each row specifies the polarity on each electrode of the electrode array 18 (FIGS. 1 and 2) that the stimulation system determines should be applied to the patient for a particular purpose. The electrode array 18 preferably comprises eight or sixteen electrodes, but the measurement table may only utilize a subset of the electrode array 18, for example four electrodes. Those skilled in the art will recognize that a measurement table may include stimulation parameter sets with various variations, such as pulse duration or pulse frequency, and a measurement table with such other variations is intended to come within the scope of the present invention. An exemplary simplified measurement table that may be used with the invention is found in Appendix A.
  • The steering table, or equivalent, typically includes a larger number of rows than does the measurement table. An exemplary steering table, containing 541 rows, that may be used with the invention is found in Appendix B. The rows in the steering table typically reflect the same variation as the rows in the measurement table, however, those skilled in the art will recognize that the steering table may also include other degrees of variation not included in the measurement table, and these variations are also intended to come within the scope of the invention. At least one row in the steering table will however correspond to one of the rows in the measurement table, as will be made apparent by the following description.
  • The rows in the steering table are arranged in order based on the physical characteristics of the stimulation provided by each stimulation parameter set, so that moving from one row to the next in the steering table represents a gradual, and somewhat uniform, change in stimulation. In other words, stepping from one row to an adjacent row in the steering table causes the stimulation applied to the tissue through the individual electrodes of the electrode array 18 to gradually move in a desired direction. This type of current steering is described more fully in U.S. Pat. No. 6,393,325, incorporated herein by reference.
  • Once the desired measurement table and steering table have been provided, the first step in the method is selection of a trial stimulation parameter set (block 24). Generally, the first row of the measurement table will be tested first, followed in order by the remaining rows. However, the order of row selection is not essential, and the rows may be selected in any order. Next, the selected stimulation parameter set is used to provide stimulation to the patient (block 26). Generally, to avoid uncomfortable “jolting” and over-stimulation, the amplitude of the stimulation provided is initially set to a relatively low level, i.e., below the level that will result in the patient perceiving paresthesia. The amplitude is then gradually increased. The stimulation level at which the patient begins to perceive paresthesia is called the perception or perceptual threshold. See e.g., U.S. Pat. No. 6,393,325, noted above. The stimulation is then increased until it begins to become uncomfortable for the patient. This level is called the maximum or discomfort threshold. See e.g., U.S. Pat. No. 6,393,325, noted above. These pre-steering measured thresholds may be noted and used later in the steering process. Alternatively, these thresholds may be determined based on pre-established values, or based on previously-measured thresholds for the patient.
  • The patient provides feedback as to the effectiveness of the stimulation that has been applied using the trial stimulation parameter set. Alternative means (e.g., objective measurements of various physiological parameters of the patient, such as perspiration, muscle tension, respiration rate, heart rate, and the like) may also be used to judge the effectiveness of the applied stimulation. A determination is then made if all of the trial sets have been tested (block 28). The steps of selecting a trial set of stimulation parameters (block 24) and providing stimulation in accordance with the selected trial set of stimulation parameters (block 26) are repeated until all of the trial stimulation parameter sets have been tested.
  • After all of the trial stimulation parameter sets have been tested, the trial stimulation parameter sets are ranked (block 30) based upon the patient's evaluation (and/or based upon alternative evaluation of selected physiological parameters of the patient) of the effectiveness of each trial stimulation parameter set.
  • The testing and ranking of the trial stimulation parameter sets provides a coarse approximation of the stimulation which may be most effective. Because the, trial stimulation parameter set is only a coarse approximation, the implication is that fine adjustments of such parameter sets may also be effective, and perhaps even more effective. Hence, once the trial stimulation parameter sets have been ranked, the highest ranked trial stimulation parameter set becomes a first specified ranked set that functions as a first “benchmark,” or starting point, for a much finer search for the most effective stimulation parameter set. The finer search for a stimulation parameter set begins by selecting a row in the steering table that corresponds to the highest ranked set in the measurement table (block 32 a). This selected highest ranked trial stimulation parameter set is then used to provide stimulation (block 34 a) to the patient. Again, the patient evaluates the effectiveness of the stimulation, and/or alternative means (e.g., measuring physiological parameters of the patient) are used to evaluate the effectiveness of the stimulation. Then, a row next to the row just tested, e.g., moving in a first direction in the steering table, such as down, is selected as a possible new stimulation parameter set (block 36), and this new row is then used to provide stimulation (block 34 b). The results of the new stimulation are then compared to the results of the previous stimulation (block 38 a). If the results improve (YES branch of block 38a) the steps set forth in blocks 36 and 34 b are repeated, i.e., the row in the steering table adjacent to the most recently used row, moving in the same direction in the table as before, is used to define a new stimulation parameter set (block 36) and that stimulation parameter set is used to provide stimulation (block 34 b). As long as the stimulation results continue to improve, this process of stepping to the next row in the steering table and retesting is continued, thereby fine tuning the stimulation parameter set until no further improvements are detected.
  • As soon as the results fail to improve (NO branch of block 38), the method goes back to the “benchmark” parameter set, i.e., that row in the steering table corresponding to the highest ranked set (block 32 b) and stimulation is again provided (block 34 c). This is actually a repeat of the stimulation performed at blocks 32 a and 34 a, but inasmuch as one or more stimulation parameter sets have been provided since the benchmark stimulation was provided at steps 32 a and 34 a, this repeat stimulation provides the patient with a reminder or refresher of what the benchmark stimulation was like. (Alternatively, of course, this repeat of the benchmark stimulation could be skipped.) Then, a process almost identical to that described above is performed to again fine tune the benchmark stimulation parameter set, only in the other direction. That is, the row adjacent to the row that defines the benchmark stimulation parameter set is selected as the row that defines the stimulation parameter set (block 40), moving in the opposite direction, e.g., up, from the direction used in the step performed at block 36. Once a row is selected, stimulation is provided using the parameters of the selected row (block 34 d). Thus, the fine tuning that occurs at steps 40 and 34 d in FIG. 3 occurs while moving in the opposite direction in the steering table than was used previously.
  • The results of the new stimulation applied at step 34 d are compared to the results of the previous stimulation (block 38b). If the results improve (YES branch of block 38 b), the steps set forth in blocks 40 and 34 d are repeated, i.e., the row in the steering table adjacent to the most recently used row, moving in the same direction in the table as before, are used to define a new stimulation parameter set (block 40), and that stimulation parameter set is used to provide stimulation (block 34 d). As long as the stimulation results continue to improve, this process of stepping to the next row in the steering table, and retesting is continued, thereby fine tuning the stimulation parameter set until no further improvements are detected.
  • Hence, it is seen that thus far in the method, two sets of effective stimulation parameters have been identified: one by moving in a first direction from the benchmark row (of the specified ranked set) in the steering table (determined using the steps at blocks 36, 34 b and 38 a), and another by moving from the benchmark row in a second direction in the steering table (determined using the steps at blocks 40, 34 d and 38 b). These two possible stimulation sets are then evaluated to see if one comprises the most effective stimulation set (block 42). If so (YES branch of block 42), then that set is selected as the best parameter stimulation set for the stimulation that is to be provided (block 46) whenever the operating program of the SCS system (or other neural system) determines stimulation is needed. If not (NO branch of block 42), then the search continues for the most effective stimulation set by selecting the row in the steering table corresponding to the next highest ranked set (block 44), e.g., the second ranked stimulation set. The next highest ranked set thus defines a new specified “benchmark” stimulation set from which additional fine tuning is performed as described above (blocks 32 a through 38 b).
  • It is thus seen that unless an effective stimulation parameter set is found at block 42, the process described in FIG. 3 is repeated for the next highest ranked trial stimulation parameter set, until the most effective stimulation parameter set is identified.
  • By way of a simple example, consider the Simplified Measurement Table found in Appendix A and the Simplified Steering Table found in Appendix B. After testing each of the stimulation parameter sets defined by the rows in the Simplified Measurement Table in Appendix A, the following “coarse” ranking in effectiveness of the stimulation sets is found:
    Stimulation Set Rank
    3 1
    1 2
    2 3
    4 4
  • Starting with the highest ranked Stimulation Set (from the Simplified Measurement Table in Appendix A), which uses Electrode Number 3 as an anode (+) and Electrode Number 5 as a cathode (−) to provide a stimulus to the patient, a corresponding row in the Simplified Steering Table (in Appendix B) is found to be Stimulation Set No. 301, which shows that the current flow from Electrode 3 is “1” and the current flow from Electrode 5 is “−1”. This means that all of the current applied by the stimulator is applied from Electrode 3 as an anode to Electrode 5 as a cathode. (The amplitude of the current applied may, of course, be adjusted as required.) Thus, the coarse adjustment provided by the measurement table leads one to Stimulation Set No. 301 in the Simplified Steering Table. Stimulation Set No. 301 thus serves as the first “benchmark” stimulation set.
  • Once the first benchmark stimulation set is identified, the method then fine tunes this selection by applying the stimulation set(s) adjacent the benchmark set. For example, going “down” in the Simplified Steering Table, Stimulation Set No. 302 is applied, then No. 303, and then No. 304, and so on, until the patient (or other means) determines that no further improvement results. In this example, Stimulation Set No. 302 is found to be the most effective set.
  • In a similar manner, going “up” in the Simplified Steering Table from the benchmark set (No. 301), Stimulation Set No. 300 is applied, then No. 299, then No. 298, and so on, until the patient (or other means) determines that no further improvement results. In this example, Stimulation Set 298 is found to be the most effective set to use.
  • Once the two Stimulation Sets No. 298 and 302 have been identified, then a determination is made as to which one is the most effective to use for stimulation. If one of these two is the most effective, e.g., Stimulation Set No. 298, then that Stimulation Set is selected as the best one to use for stimulation in this instance, and the search ends. If, however, neither is found to be the most effective, then the process continues by locating the second-highest ranked benchmark stimulation set (corresponding to Stimulation Set No. 1 in the Simplified Measurement Table) in the Simplified Steering Table. As seen from the Simplified Measurement Table, Stimulation Set No. 1 defines Electrode No. 1 as a cathode and Electrode No. 3 as an anode. This corresponds to Stimulation Set No. 21 in the Simplified Steering Table. Hence, fine tuning of this benchmark stimulation set is conducted by first going “down,” and then “up” from Stimulation Set No. 21 until the stimulation set is found that does not result in any further improvement.
  • The two stimulation sets identified from fine tuning the second benchmark stimulation set (one by moving “down” from the benchmark row and the other by moving “up” from the benchmark row) are then evaluated to determine if one if the most effective to use for stimulation. If one of these two is the most effective, then that stimulation set is selected as the best one to use for stimulation in this instance, and the search ends. If, however, neither is found to be the most effective, then the process continues by locating the third-highest ranked benchmark stimulation set (corresponding to Stimulation Set No. 2 in the Simplified Measurement Table) in the Simplified Steering Table, and the process continues as described.
  • Those skilled in the art will recognize that various variations exist to the method described herein. For example, a gradient method may be utilized to evaluate the slope of stimulation parameter set effectiveness around each trial stimulation parameter set. A combination of the relative effectiveness of each trial stimulation parameter set, and the slope of the effectiveness in the neighborhood of the trial stimulation parameter set may be used to select which trial stimulation parameter set to test around. The basic core of the present invention is to use a table, or equivalent, of a small number of trial stimulation parameter sets (a coarse table) to determine a starting point, and a larger table (a fine table), or equivalent, of predetermined stimulation parameter sets to guide the search for a local optimum. Any method for finding an effective stimulation parameter set that uses a combination of a small coarse table, and a large fine table, is intended to come within the scope of the invention.
  • Related methods may be used to ensure an effectual lead placement during a surgical procedure to implant a lead. A flow chart depicting one embodiment of these methods is shown in FIG. 4.
  • Using normal surgical techniques, a lead 16 containing an electrode array 18 is placed epidurally next to a patient's spinal cord in a location believed to be the correct location for effective treatment (block 50). This location may be estimated based on, for instance, mapping the location of the pain to spinal segments via dermatome maps. Once the lead is in place, it is connected to a pulse generator. The pulse generator may be an external trial stimulator (ETS), an implantable pulse generator (IPG) 12 or another source of stimulation. The lead may be connected directly to the pulse generator, or may be electrically connected, for instance, via a lead extension 14 and/or an operating room (OR) cable. The ETS, IPG, lead extension and OR cable are described in more detail in U.S. Pat. No. 6,516,227, discussed above.
  • Once the lead is in place and connected to the pulse generator, stimulation is activated (block 52). In one embodiment, a steering table such as the steering table shown in Appendix B is used to define the stimulation parameters. In such a table, the table entries are arranged so that the electric field properties of the stimulation defined by parameters in adjacent rows are similar. This is accomplished by having the rows arranged in order based on the characteristics of the stimulation provided by each stimulation parameter set, so that moving from one row to an adjacent row in the steering table causes a gradual change in stimulation. For example, rows 21 to 41 of the table in Appendix B define stimulation parameters representing a gradual transition of an anode from electrode 3 to electrode 4. The electric field properties of the stimulation defined by the parameters in these rows are similar, such that a transition from row 21 to row 41 has the effect of gradually moving the anode from electrode 3 to electrode 4.
  • Once the stimulation has been activated, the process of “electronic trolling” (block 54) can begin. In one embodiment, the steering table is arranged such that stimulation is first provided by an electrode located at one end of the electrode array. The entries of the table are arranged so that the stimulation is gradually transitioned to an adjacent electrode, then another adjacent electrode, and so on, until the stimulation has been transitioned along the entire length of the array. The number of steps used to transition along the entire array, and thus the number of entries in the steering table used for trolling, depends on many factors. These factors include the number of electrodes in the array and the maximum step size that will not produce an uncomfortable “jolt” to the patient. Additionally, the amount of time the surgeon and/or patient wants to spend trolling and the amount of time the patient can tolerate trolling must be weighed against the desired electric field shift resolution. If too large of a step size is selected, a group of effective stimulation parameter sets might be inadvertently skipped during the trolling process and the location of the lead may be incorrectly judged to be ineffective. The number of steps or step size may be programmable and selectable by the surgeon and/or clinician, or may be pre-programmed in software. Once the number of steps or step size is determined, a steering table for use in trolling can be created or can be selected from an existing table. Alternatively, particular rows from a larger steering table may be selected for use in the trolling process.
  • In another embodiment, the stimulation is first provided by an electrode or set of electrodes that is not at the end of the array. For example, several electrodes in the middle of the array may be used to provide stimulation. The stimulation is then transitioned in one direction along the array to one end of the array. The stimulation may then be transitioned back to the middle of the array and to the opposite end of the array. In this way, stimulation is provided from electrodes located in different regions of the array. Any combination or pattern in which stimulation is transitioned along the length of the array is intended to fall within the scope of these methods.
  • Furthermore, the methods discussed above are not limited to use with a steering table. Any method in which stimulation is transitioned along the electrode array may be used. For example, stimulation may be defined by parameters specified by software, which may define multiple sets of stimulation parameters. As another example, stimulation may be activated in one portion of an array and an algorithm may be used to transition stimulation from that portion of the electrode array to another or from one end of the array to the other without the use of a steering table. Fixed step sizes may be used to transition stimulation, or a method such as the method disclosed in co-pending U.S. application Ser. No. ##/###,###, filed Dec. 30, 2004 entitled “Method for Optimizing Search for Spinal Cord Stimulation Parameter Settings” and incorporated herein by reference, may be used to determine the appropriate step sizes to use for electronic trolling.
  • In order to maximize the benefit of the methods discussed above, the electronic trolling process preferably involves electrodes from all regions of the array. If the trolling process involves less than the entire array, then a relatively smaller region of the patient's spinal cord is stimulated during the trolling process and the lead may have to be repositioned a greater number of times. To avoid this less efficient result and to gain the maximum benefit of the methods discussed above, a representative number of sets of stimulation parameters are preferably used during the trolling process. This means that sets of stimulation parameters defining stimulation in all regions of the electrode array are preferably used, and that a sufficient number of sets are preferably used. The number of sets required depends on several factors, including the number and size of electrodes, the inter-electrode spacing, the patient's anatomy and the location(s) and total area of the patient's pain. This number is preferably chosen so that the electric field and the resulting paresthesia do not shift too much with each transition in the trolling process, and so that stimulation is provided from all regions of the electrode array.
  • Similarly, in order for electronic trolling to be most effective, the electrical stimulation should be of a strong enough intensity to produce paresthesia along the entire length of the array. Any method that accomplishes this can be used, including giving the patient the ability to manually adjust the intensity of the stimulation up and down as the stimulation is transitioned. Alternatively, an algorithm, such as the SEQ algorithm described in co-pending U.S. application Ser. No. ##/###,###, discussed above, may be used to maintain a relatively constant stimulation intensity as the stimulation is transitioned. As the electric field produced by the stimulation is shifted, the location on the patient's body where paresthesia is sensed will also shift. The goal of the trolling process is to ensure the effective placement of an electrode array such that the location of the induced paresthesia is effective, i.e., so that the location of the induced paresthesia matches the location of the pain when the electrode array is located in a particular place.
  • Thus in the next step of the method, the patient reports whether the paresthesia generated by the stimulation is located in approximately the same location as the pain (block 56). The patient may provide feedback during the trolling process, or may be asked at the conclusion of the trolling process whether the location of the paresthesia matched the location of the pain at any time during the process. If the location of the paresthesia sufficiently matches the location of the pain, then the lead is in an effective position and the trolling process is complete (block 58). The surgeon then secures the lead in position, using a lead anchor or other means. The process of determining effectual stimulation parameter sets, for example as shown in FIG. 3 and described above, may then begin (block 64).
  • If the patient reports that the area(s) of paresthesia generated by stimulation do not sufficiently overlap the area(s) of pain, then the stimulation may optionally be deactivated (block 60), the lead is repositioned in the epidural space (block 62) and the steps shown in blocks 52-56 are repeated. This process of optionally deactivating stimulation, repositioning the lead, and repeating the steps in blocks 52-56 is repeated until the patient reports that the paresthesia generated by the stimulation sufficiently matches the location of the pain.
  • Thus, electronic trolling has a similar effect as physical trolling in that the location of the electric field produced by the stimulation moves with respect to nerves in the spinal cord. However, unlike physical trolling, the lead need not be moved while the stimulation is active. Instead, the stimulation provided by the electrode array is moved along the array electronically by changing which electrode or electrodes are providing stimulation. Also unlike physical trolling, the lead is not moved unless the patient reports that the paresthesia produced by the stimulation does not sufficiently match the location of the pain. This results in a simpler surgical procedure with less risk of damage to tissue surrounding the lead or to the spinal cord itself. Additionally, because stimulation is not deactivated between testing each electrode combination, electronic trolling saves time over conventional methods which require stimulation to be ramped up and down in order to test each combination.
  • While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims. For example, the methods discussed above are not limited to spinal cord stimulation systems and may be used with many kinds of stimulation systems such as cochlear implants, cardiac stimulation systems, peripheral nerve stimulation systems, brain stimulation systems and microstimulators.

Claims (20)

1-15. (canceled)
16. A method for determining an effectual placement of an electrode array during a surgical implant procedure comprising:
(a) placing a lead having electrodes in a first location in a patient;
(b) activating electrical stimulation to produce paresthesia;
(c) electronically trolling the length of said electrode array;
(d) determining whether the paresthesia is in an effective location;
(e) if the paresthesia is not in an effective location, moving the lead to a different location and repeating steps (b) through (d).
17. The method according to claim 16, wherein the electrical stimulation is defined by parameters specified by software.
18. The method according to claim 17, wherein the software comprises a steering table.
19. The method according to claim 18, wherein the steering table comprises multiple rows containing stimulation parameters for one or more electrodes.
20. The method according to claim 19, wherein the rows are arranged so that the electric field properties of adjacent rows in said steering table are similar.
21. The method according to claim 20, wherein electronically trolling comprises:
moving the electrical stimulation from a first position on the electrode array to a second position on the electrode array.
22. The method according to claim 16, wherein electronically trolling comprises:
electronically moving the electrical stimulation from a first position on the electrode array to a second position on the electrode array.
23. A method for determining an effectual placement of an electrode array during a surgical implant procedure comprising:
(a) placing a lead having electrodes in a first location in a patient;
(b) providing electrical stimulation to produce paresthesia, the electrical stimulation defined by a first set of stimulation parameters specified by software;
(c) determining whether the paresthesia is in an effective location;
(d) providing electrical stimulation defined by a different set of stimulation parameters specified in software;
(e) determining whether the paresthesia is in an effective location;
(f) repeating steps (d) and (e) until effective paresthesia is obtained or all sets of stimulation parameters specified by software have been provided;
(g) if effective paresthesia is not obtained, moving the lead to a different location; and
(h) repeating steps (b) through (g) until effective paresthesia is obtained.
24. The method according to claim 23, wherein the software comprises at least one steering table containing rows corresponding to sets of stimulation parameters.
25. The method according to claim 24, wherein the rows are arranged so that the electric field properties of adjacent rows in said steering table are similar.
26. The method according to claim 23, wherein the software comprises at least one algorithm specifying sets of stimulation parameters.
27. The method according to claim 23, wherein repeating step (d) results in a gradual transition of stimulation from a first position on the electrode array to a second position on the electrode array.
28. A method for determining an effectual placement of an electrode array for the treatment of pain comprising:
(a) placing a lead having electrodes in a first location in a patient;
(b) providing electrical stimulation to produce paresthesia, the electrical stimulation defined by a first set of stimulation parameters contained in a steering table;
(c) determining whether the location of the paresthesia effectively matches the location of the pain;
(d) if it does not, providing electrical stimulation defined by a different set of stimulation parameters contained in said steering table;
(e) repeating steps (c) and (d) until effective paresthesia is obtained or electrical stimulation defined by a representative number of sets of stimulation parameters has been provided;
(f) if the location of the paresthesia still does not effectively match the location of the pain, moving the lead to a different location; and
(g) repeating steps (b) through (f) until the location of the paresthesia effectively matches the location of the pain.
29. The method according to claim 28, wherein the first set of stimulation parameters are contained in a first row of the steering table.
30. The method according to claim 28, wherein the rows of the steering table are arranged so that the electric field properties of adjacent rows in said steering table are similar.
31. The method according to claim 28, wherein providing electrical stimulation defined by a different set of stimulation parameters comprises:
providing electrical stimulation defined by stimulation parameters contained in an adjacent row of the steering table.
32. The method according to claim 31, wherein the first row of the steering table contains stimulation parameters that define stimulation to be provided at a first end of the electrode array and the row of the steering table farthest from the first row contains stimulation parameters that define stimulation to be provided at a second end of the array.
33. The method according to claim 28, wherein repeating step (d) results in a gradual transition of stimulation from a first position on the electrode array to a second position on the electrode array.
34. The method according to claim 33, wherein repeating step (d) results in a gradual transition of stimulation from the first end of the electrode array to the second end of the electrode array.
US11/031,648 2002-02-04 2005-01-07 Method for optimizing location of implanted electrode array during implant surgery Abandoned US20050203588A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/031,648 US20050203588A1 (en) 2002-02-04 2005-01-07 Method for optimizing location of implanted electrode array during implant surgery
PCT/US2005/001119 WO2006073405A2 (en) 2002-02-04 2005-01-12 Method for optimizing location of implanted electrode array during implant surgery

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35409802P 2002-02-04 2002-02-04
US10/355,955 US7146223B1 (en) 2002-02-04 2003-01-31 Method for optimizing search for spinal cord stimulation parameter settings
US11/031,648 US20050203588A1 (en) 2002-02-04 2005-01-07 Method for optimizing location of implanted electrode array during implant surgery

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/355,955 Continuation-In-Part US7146223B1 (en) 2002-02-04 2003-01-31 Method for optimizing search for spinal cord stimulation parameter settings

Publications (1)

Publication Number Publication Date
US20050203588A1 true US20050203588A1 (en) 2005-09-15

Family

ID=37684093

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/355,955 Expired - Fee Related US7146223B1 (en) 2002-02-04 2003-01-31 Method for optimizing search for spinal cord stimulation parameter settings
US11/031,648 Abandoned US20050203588A1 (en) 2002-02-04 2005-01-07 Method for optimizing location of implanted electrode array during implant surgery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/355,955 Expired - Fee Related US7146223B1 (en) 2002-02-04 2003-01-31 Method for optimizing search for spinal cord stimulation parameter settings

Country Status (2)

Country Link
US (2) US7146223B1 (en)
WO (1) WO2006073405A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070265679A1 (en) * 2002-02-04 2007-11-15 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter setting
US20080114416A1 (en) * 2006-11-13 2008-05-15 Advanced Bionics Corporation Stimulation programmer with clinically-adaptive modality
WO2008121404A1 (en) * 2007-03-30 2008-10-09 Kyphon Sarl Methods and systems for the diagnosis and treatment of medical conditions in the spine and other body parts
US20090287279A1 (en) * 2008-05-15 2009-11-19 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US20100023069A1 (en) * 2008-07-24 2010-01-28 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US20130253610A1 (en) * 2012-03-23 2013-09-26 Boston Scientific Neuromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US8588936B2 (en) 2010-07-28 2013-11-19 University Of Utah Research Foundation Spinal cord stimulation system and methods of using same
US9227065B2 (en) 2002-02-04 2016-01-05 Boston Scientific Neuromodulation Corporation Method for programming implantable device
US20170189684A1 (en) * 2012-03-20 2017-07-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Monitoring and regulating physiological states and functions via sensory neural inputs to the spinal cord
US10426949B2 (en) 2016-10-26 2019-10-01 Regents Of The University Of Minnesota Systems and methods for optimizing programming and use of neuromodulation systems
US10561848B2 (en) 2015-10-13 2020-02-18 Regents Of The University Of Minnesota Systems and methods for programming and operating deep brain stimulation arrays
US10773074B2 (en) 2014-08-27 2020-09-15 The Regents Of The University Of California Multi-electrode array for spinal cord epidural stimulation

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7463928B2 (en) * 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy
US8180601B2 (en) 2006-03-09 2012-05-15 The Cleveland Clinic Foundation Systems and methods for determining volume of activation for deep brain stimulation
US8209027B2 (en) 2004-07-07 2012-06-26 The Cleveland Clinic Foundation System and method to design structure for delivering electrical energy to tissue
US7346382B2 (en) 2004-07-07 2008-03-18 The Cleveland Clinic Foundation Brain stimulation models, systems, devices, and methods
US8774912B2 (en) * 2005-02-23 2014-07-08 Medtronic, Inc. Implantable neurostimulator supporting trial and chronic modes
US8768452B2 (en) * 2005-02-23 2014-07-01 Medtronic, Inc. Implantable neurostimulator supporting trial and chronic modes
US8589316B2 (en) 2009-08-27 2013-11-19 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
US8606360B2 (en) * 2006-03-09 2013-12-10 The Cleveland Clinic Foundation Systems and methods for determining volume of activation for spinal cord and peripheral nerve stimulation
US7774067B2 (en) * 2006-04-12 2010-08-10 Medtronic, Inc. Autogeneration of neurostimulation therapy program groups
US8712539B2 (en) 2006-04-12 2014-04-29 Medtronic, Inc. Rule-based stimulation program search
US8068918B2 (en) 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
US20080300657A1 (en) 2007-05-31 2008-12-04 Mark Raymond Stultz Therapy system
US9220889B2 (en) 2008-02-11 2015-12-29 Intelect Medical, Inc. Directional electrode devices with locating features
US8019440B2 (en) 2008-02-12 2011-09-13 Intelect Medical, Inc. Directional lead assembly
ES2580175T3 (en) 2008-05-15 2016-08-19 Intelect Medical Inc. Clinical programmer system and procedure to direct activation volumes
US9272153B2 (en) 2008-05-15 2016-03-01 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
US8249701B2 (en) * 2008-10-15 2012-08-21 Spinal Modulation, Inc. Methods, devices and systems for programming neurostimulation
US8644946B2 (en) * 2008-12-04 2014-02-04 The Cleveland Clinic Foundation System and method to define target volume for stimulation in brain
JP5830090B2 (en) 2010-06-14 2015-12-09 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Programming interface for spinal nerve regulation
US20130054270A1 (en) 2011-03-29 2013-02-28 Boston Scientific Neuromodulation Corporation Communication interface for therapeutic stimulation providing systems
US9592389B2 (en) 2011-05-27 2017-03-14 Boston Scientific Neuromodulation Corporation Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information
US9364670B2 (en) 2011-07-28 2016-06-14 Medtronic, Inc. Selection of spinal cord stimulation electrodes for use in cardiac therapy
WO2013023076A2 (en) 2011-08-09 2013-02-14 Boston Scientific Neuromodulation Corporation Control and/or quantification of target stimulation volume overlap and interface therefor
EP2741818B1 (en) 2011-08-09 2019-11-20 Boston Scientific Neuromodulation Corporation Voa generation system and method using a fiber specific analysis
WO2013023085A2 (en) 2011-08-09 2013-02-14 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing
WO2013023073A1 (en) 2011-08-09 2013-02-14 Boston Scientific Neuromodulation Corporation System and method for weighted atlas generation
WO2013033539A1 (en) 2011-09-01 2013-03-07 Boston Scientific Neuromodulation Corporation Methods and system for targeted brain stimulation using electrical parameter maps
US9081488B2 (en) 2011-10-19 2015-07-14 Boston Scientific Neuromodulation Corporation Stimulation leadwire and volume of activation control and display interface
WO2014025624A1 (en) 2012-08-04 2014-02-13 Boston Scientific Neuromodulation Corporation Techniques and methods for storing and transferring registration, atlas, and lead information between medical devices
AU2013308910B2 (en) 2012-08-28 2016-10-06 Boston Scientific Neuromodulation Corporation Parameter visualization, selection, and annotation interface
US9792412B2 (en) 2012-11-01 2017-10-17 Boston Scientific Neuromodulation Corporation Systems and methods for VOA model generation and use
US9872997B2 (en) 2013-03-15 2018-01-23 Globus Medical, Inc. Spinal cord stimulator system
WO2014144029A2 (en) 2013-03-15 2014-09-18 Boston Scientific Neuromodulation Corporation Clinical response data mapping
US9440076B2 (en) 2013-03-15 2016-09-13 Globus Medical, Inc. Spinal cord stimulator system
US9887574B2 (en) 2013-03-15 2018-02-06 Globus Medical, Inc. Spinal cord stimulator system
US9878170B2 (en) 2013-03-15 2018-01-30 Globus Medical, Inc. Spinal cord stimulator system
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
AU2014348865B2 (en) 2013-11-14 2017-06-01 Boston Scientific Neuromodulation Corporation Systems, methods, and visualization tools for stimulation and sensing of neural systems with system-level interaction models
US9959388B2 (en) 2014-07-24 2018-05-01 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for providing electrical stimulation therapy feedback
US10265528B2 (en) 2014-07-30 2019-04-23 Boston Scientific Neuromodulation Corporation Systems and methods for electrical stimulation-related patient population volume analysis and use
US10272247B2 (en) 2014-07-30 2019-04-30 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
CA2958218C (en) 2014-09-26 2021-01-19 Duke University Systems and methods for spinal cord stimulation
EP3204112A1 (en) 2014-10-07 2017-08-16 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
US10780283B2 (en) 2015-05-26 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
US9956419B2 (en) 2015-05-26 2018-05-01 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
WO2016209682A1 (en) 2015-06-23 2016-12-29 Duke University Systems and methods for utilizing model-based optimization of spinal cord stimulation parameters
US10441800B2 (en) 2015-06-29 2019-10-15 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters by targeting and steering
WO2017003946A1 (en) 2015-06-29 2017-01-05 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects
WO2017062378A1 (en) 2015-10-09 2017-04-13 Boston Scientific Neuromodulation Corporation System and methods for clinical effects mapping for directional stimulations leads
US10716942B2 (en) 2016-04-25 2020-07-21 Boston Scientific Neuromodulation Corporation System and methods for directional steering of electrical stimulation
US10776456B2 (en) 2016-06-24 2020-09-15 Boston Scientific Neuromodulation Corporation Systems and methods for visual analytics of clinical effects
US10350404B2 (en) 2016-09-02 2019-07-16 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and directing stimulation of neural elements
US10780282B2 (en) 2016-09-20 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
WO2018071865A1 (en) 2016-10-14 2018-04-19 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system
WO2018128949A1 (en) 2017-01-03 2018-07-12 Boston Scientific Neuromodulation Corporation Systems and methods for selecting mri-compatible stimulation parameters
WO2018132334A1 (en) 2017-01-10 2018-07-19 Boston Scientific Neuromodulation Corporation Systems and methods for creating stimulation programs based on user-defined areas or volumes
US10625082B2 (en) 2017-03-15 2020-04-21 Boston Scientific Neuromodulation Corporation Visualization of deep brain stimulation efficacy
US11357986B2 (en) 2017-04-03 2022-06-14 Boston Scientific Neuromodulation Corporation Systems and methods for estimating a volume of activation using a compressed database of threshold values
AU2018301355B2 (en) 2017-07-14 2020-10-01 Boston Scientific Neuromodulation Corporation Systems and methods for estimating clinical effects of electrical stimulation
US10960214B2 (en) 2017-08-15 2021-03-30 Boston Scientific Neuromodulation Corporation Systems and methods for controlling electrical stimulation using multiple stimulation fields
EP3784332B1 (en) 2018-04-27 2023-04-26 Boston Scientific Neuromodulation Corporation Systems for visualizing and programming electrical stimulation
JP7295141B2 (en) 2018-04-27 2023-06-20 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Multimodal electrical stimulation system and methods of making and using

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6622048B1 (en) * 1999-12-06 2003-09-16 Advanced Bionics Corporation Implantable device programmer

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646940A (en) 1969-07-15 1972-03-07 Univ Minnesota Implantable electronic stimulator electrode and method
US3724467A (en) 1971-04-23 1973-04-03 Avery Labor Inc Electrode implant for the neuro-stimulation of the spinal cord
US3822708A (en) 1972-12-07 1974-07-09 Clinical Technology Corp Electrical spinal cord stimulating device and method for management of pain
US4019518A (en) 1975-08-11 1977-04-26 Medtronic, Inc. Electrical stimulation system
US4793353A (en) 1981-06-30 1988-12-27 Borkan William N Non-invasive multiprogrammable tissue stimulator and method
US4520825A (en) 1982-04-30 1985-06-04 Medtronic, Inc. Digital circuit for control of gradual turn-on of electrical tissue stimulators
US5167229A (en) 1986-03-24 1992-12-01 Case Western Reserve University Functional neuromuscular stimulation system
US5531774A (en) 1989-09-22 1996-07-02 Alfred E. Mann Foundation For Scientific Research Multichannel implantable cochlear stimulator having programmable bipolar, monopolar or multipolar electrode configurations
US5354320A (en) 1991-09-12 1994-10-11 Biotronik Mess- Und Therapiegerate Gmbh & Co., Ingenieurburo Berlin Neurostimulator for production of periodic stimulation pulses
US5370672A (en) 1992-10-30 1994-12-06 The Johns Hopkins University Computer-controlled neurological stimulation system
US5417719A (en) 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5501703A (en) 1994-01-24 1996-03-26 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulator
US5769875A (en) 1994-09-06 1998-06-23 Case Western Reserve University Functional neuromusclar stimulation system
US5443486A (en) 1994-09-26 1995-08-22 Medtronic, Inc. Method and apparatus to limit control of parameters of electrical tissue stimulators
US5601617A (en) 1995-04-26 1997-02-11 Advanced Bionics Corporation Multichannel cochlear prosthesis with flexible control of stimulus waveforms
US5626629A (en) 1995-05-31 1997-05-06 Advanced Bionics Corporation Programming of a speech processor for an implantable cochlear stimulator
US5649970A (en) 1995-08-18 1997-07-22 Loeb; Gerald E. Edge-effect electrodes for inducing spatially controlled distributions of electrical potentials in volume conductive media
AU731837B2 (en) 1995-12-01 2001-04-05 Cochlear Limited A feedback system to control electrode voltages in a cochlear stimulator and the like
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
US5713922A (en) 1996-04-25 1998-02-03 Medtronic, Inc. Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US6609031B1 (en) 1996-06-07 2003-08-19 Advanced Neuromodulation Systems, Inc. Multiprogrammable tissue stimulator and method
US6393325B1 (en) 1999-01-07 2002-05-21 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6052624A (en) 1999-01-07 2000-04-18 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6587724B2 (en) 1999-12-17 2003-07-01 Advanced Bionics Corporation Magnitude programming for implantable electrical stimulator
US6546290B1 (en) 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
CA2323983A1 (en) 2000-10-19 2002-04-19 Universite De Sherbrooke Programmable neurostimulator
US6792310B1 (en) * 2001-01-12 2004-09-14 Pacesetter, Inc. Methods, systems and devices for optimizing cardiac pacing parameters
US6600954B2 (en) 2001-01-25 2003-07-29 Biocontrol Medical Bcm Ltd. Method and apparatus for selective control of nerve fibers
ATE482743T1 (en) 2002-10-31 2010-10-15 Medtronic Inc METHOD AND APPARATUS FOR USING FILTERING INFORMATION TO IDENTIFY COMBINATIONS OF ELECTRODES
US7463928B2 (en) 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6622048B1 (en) * 1999-12-06 2003-09-16 Advanced Bionics Corporation Implantable device programmer

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8065013B2 (en) 2002-02-04 2011-11-22 Boston Scientific Neuromodulation Corporation Method for optimizing search for spinal cord stimulation parameter setting
US20070265679A1 (en) * 2002-02-04 2007-11-15 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter setting
US9227065B2 (en) 2002-02-04 2016-01-05 Boston Scientific Neuromodulation Corporation Method for programming implantable device
US9687653B2 (en) 2002-02-04 2017-06-27 Boston Scientific Neuromodulation Corporation Method for programming implantabale device
US20080114416A1 (en) * 2006-11-13 2008-05-15 Advanced Bionics Corporation Stimulation programmer with clinically-adaptive modality
WO2008063851A1 (en) * 2006-11-13 2008-05-29 Boston Scientific Neuromodulation Corporation Stimulation programmer with clinically-adaptive modality
WO2008121404A1 (en) * 2007-03-30 2008-10-09 Kyphon Sarl Methods and systems for the diagnosis and treatment of medical conditions in the spine and other body parts
US20090036799A1 (en) * 2007-03-30 2009-02-05 Medtronic Spinal And Biologics Business Methods and Systems For The Diagnosis and Treatment of Medical Conditions in the Spine and Other Body Parts
US8812131B2 (en) 2008-05-15 2014-08-19 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US9782593B2 (en) 2008-05-15 2017-10-10 Boston Scientific Neuromodulation Corporation Fractionalized stimulation pulses in an implantable stimulator device
US9393423B2 (en) 2008-05-15 2016-07-19 Boston Scientific Neuromodulation Corporation Fractionalized stimulation pulses in an implantable stimulator device
US20100262210A1 (en) * 2008-05-15 2010-10-14 Boston Scientific Neuromodulation Corporation Current Steering for an Implantable Stimulator Device Involving Fractionalized Stimulation Pulses
US20090287279A1 (en) * 2008-05-15 2009-11-19 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US10293166B2 (en) 2008-05-15 2019-05-21 Boston Scientific Neuromodulation Corporation Fractionalized stimulation pulses in an implantable stimulator device
US9289610B2 (en) 2008-05-15 2016-03-22 Boston Scientific Neuromodulation Corporation Fractionalized stimulation pulses in an implantable stimulator device
US7890182B2 (en) 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US20100023070A1 (en) * 2008-07-24 2010-01-28 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US20100023069A1 (en) * 2008-07-24 2010-01-28 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US8131358B2 (en) 2008-07-24 2012-03-06 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US8055337B2 (en) 2008-07-24 2011-11-08 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US9757557B2 (en) 2010-07-28 2017-09-12 University Of Utah Research Foundation Spinal cord stimulation system
US8588936B2 (en) 2010-07-28 2013-11-19 University Of Utah Research Foundation Spinal cord stimulation system and methods of using same
US20170189684A1 (en) * 2012-03-20 2017-07-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Monitoring and regulating physiological states and functions via sensory neural inputs to the spinal cord
US11433241B2 (en) * 2012-03-20 2022-09-06 University of Pittsburgh—of the Commonwealth System of Higher Education Monitoring and regulating physiological states and functions via sensory neural inputs to the spinal cord
US9517346B2 (en) 2012-03-23 2016-12-13 Boston Scientific Neromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US9352158B2 (en) 2012-03-23 2016-05-31 Boston Scientific Neuromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US8918185B2 (en) 2012-03-23 2014-12-23 Boston Scientific Neuromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US8868198B2 (en) * 2012-03-23 2014-10-21 Boston Scientific Neuromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US20130253610A1 (en) * 2012-03-23 2013-09-26 Boston Scientific Neuromodulation Corporation Heuristic safety net for transitioning configurations in a neural stimulation system
US10773074B2 (en) 2014-08-27 2020-09-15 The Regents Of The University Of California Multi-electrode array for spinal cord epidural stimulation
US10561848B2 (en) 2015-10-13 2020-02-18 Regents Of The University Of Minnesota Systems and methods for programming and operating deep brain stimulation arrays
US10426949B2 (en) 2016-10-26 2019-10-01 Regents Of The University Of Minnesota Systems and methods for optimizing programming and use of neuromodulation systems

Also Published As

Publication number Publication date
WO2006073405A2 (en) 2006-07-13
US7146223B1 (en) 2006-12-05

Similar Documents

Publication Publication Date Title
US20050203588A1 (en) Method for optimizing location of implanted electrode array during implant surgery
US7881805B2 (en) Method for optimizing search for spinal cord stimulation parameter settings
US7991482B2 (en) Method for optimizing search for spinal cord stimulation parameter setting
US7571001B2 (en) System and method of rapid, comfortable parameter switching in spinal cord stimulation
US8233991B2 (en) Method for programming implantable device
US7127296B2 (en) Method for increasing the therapeutic ratio/usage range in a neurostimulator
US7174215B2 (en) Method for determining stimulation parameters
US7450992B1 (en) Method for controlling or regulating therapeutic nerve stimulation using electrical feedback
US7295876B1 (en) System and method for generating and testing treatment protocols
US20120253422A1 (en) Systems and methods for selecting neural modulation contacts from among multiple contacts
CN106390283B (en) Selective high frequency spinal cord modulation with reduced side effects for pain suppression, and related systems and methods
CN115243756A (en) Neural stimulation device providing sub-sensory stimulation
US20210031041A1 (en) Sub-threshold electrical stimulation therapy at a first anatomical location within a patient
CN114828944A (en) External controller for controlling sub-sensory stimuli
CN114051424A (en) Spinal cord stimulation system using neural dose determination optimized sub-perception therapy
CN113412135A (en) Altering stimulation parameters to prevent tissue habituation in spinal cord stimulation systems
WO2023137009A1 (en) Systems and methods for sub-perception parameter selection

Legal Events

Date Code Title Description
AS Assignment

Owner name: ADVANCED BIONICS CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KING, JOHN D.;REEL/FRAME:017927/0285

Effective date: 20050422

AS Assignment

Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, CAL

Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED BIONICS CORPORATION;REEL/FRAME:020296/0477

Effective date: 20071116

Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED BIONICS CORPORATION;REEL/FRAME:020296/0477

Effective date: 20071116

Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION,CALI

Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED BIONICS CORPORATION;REEL/FRAME:020296/0477

Effective date: 20071116

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION